We are very happy to welcome Atlantic Lithium CEO Vincent Mascolo #ALL #IRR, Cora Gold CEO Bert Monro #CORA and Valirx CEO Suzanne Dilly #VAL to our December Investor Webinar. Please register here.
Agreed that IQE did not deliver, although I was lucky to sell at a profit (too soon as it turned out) in Aug 2020.
I am significantly invested in IQAI but the share price will need to reach 8.5p in order for me to break even. Agreed with you about the risk when invested in AIM, and I am considering lowering my IQAI target. The last spike proved to be a swift pump and dump with a gradual share price drop to follow. Better to settle for a small profit, than to hang on to shares for a long period waiting for developments and an eventual recovery.
Regards and good wishes.
Many traders make a good living through accumulating profits of hundreds of pounds several times a week. This morning many of these traders will be cashing in their very short term gains and moving their capital elsewhere in search of more profit.
Good fortune to them, and better fortune to investors who have stuck with this company, whose share price has been in constant decline for three months. A positive RNS from Mr. Duffin would help to rectify matters further. The current rise is in anticipation of this, and the RNS is now needed to sustain it.
I am surprised to find the company in a state of “suspended animation”. There are no updates, and little further trading since the recent unexpected fall in share price. My previous research points to the fact that this company has enormous potential, and that the current MCap is well below below where it should be. Positive incoming news should catalyse a re-rate to a higher level.
Recently I have researched the current high quality air filter technology used in hospitals and elsewhere. One example is appended in a link below. It would appear that the filter material traps the airborne virus entities. Surely it wouldn’t require much adaptation to existing air filters to incorporate Nanosynth’s patented material in their air filters? I understand that Dr. Cave and his team are working on this and that proof of concept has been established. You are right in saying that potentially this could be a huge source of revenue for Nanosynth.
I am more confident about the immediate future of this company than before, and have cancelled my sell order at 1.3p. I am grateful to you and to many others on this board for keeping the faith in this company and its potential, and for always being positive. It has been reassuring that other investors had a similar vision to my own.
Regards and with my best wishes.
The short term sellers have come out to play today following an expected initial drop on the news of a CLN conversion, and accompanying share price dilution.
Long term investors tend to ignore the hype generated by short term sellers owing to their obvious interest in encouraging investors to panic sell causing further disruption.
My interest is in how this company will develop in the coming months, and in the longer term. Day by day fluctuations induced by inevitable transactions of the aforementioned kind are of little interest or consequence.
Hold firm SYME long term investors. Our day will arrive, perhaps sooner than we think.
Hello again selecta6,
I followed your recent suggestion and sent a copy of one of my posts of several weeks ago to the Investors' Relations team. Sadly, I did not receive a reply on that occasion. The silence from the company (on all fronts) is deafening, and we are all seeing the value of our shareholdings diminishing by the day.
I should have had the good sense to sell following the abrupt rise three months ago to break even. Sadly, I have continued to hold since then, but have averaged down on two occasions. I now have a sell order @ 1.3p to realise a £6K profit, but hope that the recovery goes well beyond that point so that investors who bought in at higher prices can achieve a return on their investment. We can but put our trust in Mr. Duffin for the time being. His background looks sound enough, and he may well have it in him to turn things around.
Regards, and with my very best wishes.
Thank you for your reply Dr. Micho.
It would be good to something from the company before too very long. i have just had a look at your link, and was surprised to see that so much time has elapsed since the appointment of the two directors with a scientific background (Dr. Cave and Ms. Sartain) on April 19. One can only hope that they are active behind the scenes in starting to bring this company back to life. Investors have had nothing but perfunctory notices recently, and an input from the scientifically based directors, mostly from Dr. Cave, would add some credibility. He should, however, focus on the product development side, and steer clear of business aspects. Both his performance on an investing-based podcast and Legge's interview on Proactive Investors earlier this year were underwhelming. The market demands hard facts, not irrelevant anecdotes and soundbites, and we can but hope that Mr. Duffin has an authoritative and fact-based approach in delivering future information to the market.
Regards, and with my very best wishes.
Thank you poorinvestor. Likewise, I hope that you and your family are faring well.
I look forward to Mr. Duffin finally getting to grips with his CEO role, and implementing some strategies to add value to this company. The potential here is considerable, and investors would welcome some action to implement it.
Regards and best wishes.
Thus far, Mr.Duffin’s appointment has only served investors with disappointment. He has overseen a linear fall of greater than 50% in Nanosynth’s share price, continuously over three months. Additionally, he has uncoupled a minor subsidiary and parted company with an underwhelming Chairman.
There has been no meaningful communication regarding sales, contract wins, future strategy, or product development to stimulate the market. It is high time for the quiet man to signal to investors that Nanosynth is a viable business with a future. The negative contributors to this board are being given an easy ride. My green rectangle tally indicates that they are playing on the CEO’s inaction. He has a lot of work in front of him if he wishes to restore investor confidence. His current silence can only result in a continuation of the death by a thousand cuts scenario that he is imposing on the share price.
All your contributions to this forum serve to draw the attention of Synairgen investors to alternative Covid therapies "in competition"? with Synairgen. Our investment continues to make daily progress towards a successful trial outcome, emergency use authorisation, manufacture and distribution. This may well happen in early 2022 when the World will still be in the grip of this terrible pandemic. Despite this, you keep banging the same drum in a rather pathetic attempt to downplay our investment. As you have nothing of value to add, it would be appreciated if you went elsewhere to support the products that you favour so much. Regards.
The evidence in favour of a successful outcome to the Sprinter trial continues to grow. This is furnished not only by the volume of scientific evidence (remember that slide in Richard Marsden's recent presentation which showed a stack of published, and verified, research papers supporting the product), but also from the company's recent high quality recruitment of experts, presuably with multiple EUAs resulting in mass manufacture and distribution in mind, and further by Polygon's significant and growing stake in the company.
I remain puzzled that the expected "fomo" factor has yet to materialise? The share price remains anchored just below the November placement price. It is ironic that a trader with the will to dare could have made a fortune from this share during the course of the last year. It crossed my mind to sell @ c.190p on a few occasions, but I lacked the courage to speculate having no idea of what was to follow. I do not regret my decision as I have a good chance of an appreciable return on my investment early next year.
My original target last November was 300p in 18 months or so. I would still be satisfied with that outcome though it would appear that most investors on this forum believe that a possible buyout could result in considerably higher terminal share price. Whatever happens, I have enjoyed this journey and learned a great deal from the experience. I look forward to learning how it progresses (or ends) during the early months of 2022.
I agree with your outline predictive timeline for positive news. As we are due another confirmatory update in the near future, it will be interesting to observe whether there will be a positive FOMO reaction before today's market close? It would appear that traders are still chancing their arm at this late stage of a long journey? The fluid shares, are still being bought and sold at low prices when one considers the immense volume of confirmatory information supporting a successful outcome to the ongoing SNG001 trials. Sooner rather than later, I believe that a catalyst will emerge to promote the share price to a considerably higher level than at present. At that point there will be no further scope for AIM pump and dump. My question is whether undecided potential investors will make a move prior to the announcement of the catalysing RNS? Today may well be close to their last chance to climb on board before the Synairgen bandwagon starts to roll?
From Ragz's last unsubstantiated act of disinformation on 28 July:
"Looks like global covid cases are coming down. UK are leading the way with covid cases dropping daily!
Great signs that the vaccines are doing their job! Not sure if SNG will have a big market place or any place if numbers of covid cases keep on dropping the way they are."
From this morning's Daily Telegraph:
" When the Prime Minister said he could see "storm clouds" gathering over parts of continental Europe, he was not wrong. Europe is again at the epicentre of the coronavirus pandemic with a new wave of infections that has swept in from the East now forcing new lockdowns and pushing hospitals to the brink in parts of western Europe. Austria is the first European country to impose a nationwide lockdown on the unvaccinated and Germany (above) is also battling a surge in cases. Europe's fourth wave started in September in eastern Europe where vaccine rates in many countries are spectacularly poor and few, if any, restrictions were in place."
The above part article is part of the well-documented global scenario which is decidedly grim.
Ragz's approach attempts to disrupt a mostly positive bulletin board. He/she is unlikely to have any insights or specialised knowledge other than that which is commonly available to everyone. If the latter were the case he/she would be unlikely to share it; instead he/she would use it for their own pecuniary advantage. Yet another failed attempt from a self-proclaimed soothsayer.
"Will no one rid me of this turbulent priest?"
I have just topped up my holding with an additional 2,000,000 shares. On attempting to dummy sell my entire holding, it was interesting to note that I received an offer for the entire 6,000,000 shares at virtually the same price per share as in my earlier top up. This equity is being actively traded, and I have every hope that with an appropriate catalyst RNS announcement, the share price will rise to an appreciably higher level.
My assumptions are based on my own research. Usual caveats, DYOR etc.
Sadly, the ongoing negativity we are too regularly subjected to by deliberate destabilisers is part of the pump and dump cycle we have witnessed yesterday and today. If they have timed their actions appropriately, they will have benefited, while investors like myself continue to hold.
The blame for the current situation, which allows the destabilising manipulators to induce fear in the minds of inexperienced investors, lies with inattentive Nanosynth directors. As long as they continue to allow this business to drift without positive input, this situation will unfortunately continue. It is high time for Mr.Duffin to inform the market concerning his future strategy. The actions that have been taken in recent months add no value whatsoever to the company. It needs sales figures, new contract wins, and information regarding the advancement of new products. Without them the company will continue to founder, and its fluctuating low-level MCap will be controlled by destabilisers, who will continue to flourish from the board's inaction.
It is good to follow the recent stream of positive information on this board. This continues to reaffirm my belief in SNG001, and in the abilities of Richard Marsden and his team in bringing the product to regulatory approval, and, subsequently, in winning contracts for its Worldwide distribution.
All this will happen, and it is important to disregard the drip-drip, subtle or otherwise, narratives that are being perpetrated by occasional contributors, whose sole purpose is to sow doubt in the minds of investors. I now wonder why this unfortunate process is still continuing despite the fact that the product is substantially de-risked, and that Richard Marsden is currently very visible, and carrying out an effective role in marketing the company on a number of forums?
My only answer is that these individuals are professional destabilisers, whose aim is to place shares in the safekeeping of large entities, who are building a stake. Their tactics may well work with inexperienced investors, who are insufficiently versed in the company's history, and the scientific evidence underpinning its anticipated future success? The attempted destabilisation is currently more subtle than that of previous attempts, from which the PowerPointed pilot's pal notably springs to mind. The recent contribution from an alleged researcher in the field from several decades ago was one of the least subtle. It was akin to comparing my current state of the art iMac system with my first computer, a BBC micro connected to my bedroom colour portable TV, and using my cassette recorder for data storage.
Let these individuals continue with their silly games. I intend to remain invested in Synairgen, at my current level of nearly a year's standing, for the foreseeable future. A take-over may force me to sell in due time, but meanwhile I intend to continue with this fascinating investor's journey.
The Nanosynth share price is currently suffering from a lack of information from the company. It is disappointing that it has reached the previous low, almost linearly from the most recent "high" level that it reached following the surge at the end of August.
We have seen directorship change in recent months, and it is high time for an effective relaunch piloted by Mr. Duffin and Dr. Cave. Rebranding the company, and selling off assets are helpful, but not substantive in themselves. As I have so often stated, the market now needs information regarding product sales and new contract wins from Mr. Duffin. Dr. Cave should restrict himself to announcements on product development, where his expertise, and nanotechnology jargon could be brought to bear. He should refrain from communicating about matters for which the CEO and other more business-focused directors are better suited . Some of his previous ventures into that territory showed his naivety in business practices, and might even have had a detrimental effect.
The bottom line is that the share price is currently foundering due to the apparent lack of progress in promised developments. It is high time for Mr. Duffin, Dr. Cave, and the other (presumably) well paid directors to get a grip on the situation and relaunch Nanosynth as a viable enterprise.
I remain quietly confident but will buy no further shares, even at these low levels, until I perceive that some progress will be forthcoming.
Contributors to this bulletin board have been adding articles supporting this well known fact over the last year. Here is another article from this morning's Telegraph healthcare supplement, which strongly supports my viewpoint, and the strict actionthat my family have continued to maintain since the start of the pandemic. Like Professor Spector, I fail to understand the attitude shown and the measures taken by the Government when restrictions were relaxed. At the very least, I believe that masks should be worn, and appropriate distancing measures maintained in supermarkets, and on public transport.
"Vaccines alone are not enough to control coronavirus and current measures are “insufficient”, an expert has said.
Tim Spector, professor of genetic epidemiology at King's College London, warned that this coming Christmas is not the only one to be worried about, and that Covid could be a concern for the next five years.
Speaking online at the Royal Society of Medicine's Covid-19 series, the lead scientist on the Zoe Covid Study app said experts now have a better picture than they did last year, when they thought they just had to get through the year.
Prof Spector said: “And that's clearly turning out not to be the case, as we realise that just vaccines alone, even in countries that have got higher vaccination rates than ours, are not the final solution to this. But we need a combination of measures.
“We need to extend the vaccination programme to include three shots.
“We also need to realise there will be breakthrough infections that are real, we now know that vaccinated people can still transmit the virus, and that is going to be running through our populations to some degree.
“How high we want those rates to be is highly determined by our complacency and our relaxation of some of the rules that we had in place, that last year I thought we're actually over the top, and now this year, I think insufficient.”
He added that bringing restrictions to an end in July, when the UK was doing well with vaccinating people, gave the impression there was a “black and white” answer to the pandemic."
HelloSanDiego. "Every relevant fact is worth considering. Even the ones you don't like."
Fact, or opinion based on dated information?
Sakura7's posts are similar in style to one of your earlier contributions.
"The British Medical Research Council's Common Cold Research Unit laboured for 43 years (1946–1989) without discovering a cure. Several compounds with promising anti-rhinovirus activity in vitro failed to demonstrate useful clinical activity. Both a- and ß-interferon, given intranasally before viral challenge, were shown to be effective in protecting against rhinovirus, coronavirus, influenza and RSV infection; however, local side-effects and the fact that they were most effective given prophylactically inhibited their utility in these indications."
Same person or tag team? It makes no difference to me. My research points me in a diametrically opposite direction to that adopted by you/Sakura7.